1-(Naphthalen-1-yl)cyclopropane-1-carbonitrile, 98%, 1g

2-(5,7-Dioxo-5,7-dihydro-pyrrolo[3,4-b]pyridin-6-yl)-ethanesulfonyl chloride, 95.0%, 250mg

2-Chloro-3-ethynylpyridine, 97%, 100mg

Azure C�, 40.0%, 5g

3-butyl-5-chloro-1-phenyl-1H-pyrazole-4-carbaldehyde, 95.0%, 2g

Fmoc-Val-Cit-PAB, 5g

7,8-dimethylbenzo[g]pteridine-2,4(1H,3H)-dione, 95.0%, 5g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 4 - MWCO 12,000 to 14,000, 10 mm, 30 m, 1 Piece(s)

(4-((2-Fluorophenyl)carbamoyl)phenyl)boronic acid, 95.0%, 250mg

2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-enone, 95.0%, 100g

METHYL 1-(AMINOMETHYL)CYCLOPROPANECARBOXYLATE HCL, 95.0%, 100mg

Methyl 3-amino-5-ethoxybenzoate, 99.0%, 250mg

5- tert -Butyl-2-hydroxy-benzaldehyde, 95.0%, 100g